Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/10/1998CA2292478A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998CA2292471A1 A method of treating cancer
12/10/1998CA2292398A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291661A1 New human ribonuclease
12/10/1998CA2291647A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291624A1 Carboxamides useful as 5-ht1f agonists
12/10/1998CA2291153A1 Benzonaphthyridine
12/10/1998CA2290695A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998CA2289524A1 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2283319A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882726A1 Carbazol-carboxamides as 5-HT1F agonists
12/09/1998EP0882718A1 Benzimidazole derivatives
12/09/1998EP0882707A1 Novel tricyclic compounds and drug compositions containing the same
12/09/1998EP0882706A1 Cell adhesion inhibitors
12/09/1998EP0882451A1 Glycine for prevention or treatment of transplant rejection
12/09/1998EP0882128A1 Cell-based assay
12/09/1998EP0882047A1 Quinolones and their therapeutic use
12/09/1998EP0882046A1 Quinolones and their therapeutic use
12/09/1998EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998EP0882040A1 Antagonists of gonadotropin releasing hormone
12/09/1998EP0882039A1 Endothelin receptor antagonists
12/09/1998EP0882038A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/09/1998EP0882024A1 Retroviral protease inhibiting compounds
12/09/1998EP0882023A1 Histamine h 3 receptor ligands
12/09/1998EP0882022A1 Aspartyl protease inhibitors
12/09/1998EP0882016A1 Alkylated styrenes as prodrugs to cox-2 inhibitors
12/09/1998EP0882015A1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors
12/09/1998EP0881908A1 Use of fibroblast growth factors to stimulate bone growth
12/09/1998EP0810866A4 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/09/1998EP0712390B1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1201461A Fused tropane-derivatives as neurotransmitter reuptake inhibitors
12/09/1998CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
12/09/1998CN1201397A Improved prescription for steroid compound administration
12/09/1998CN1201394A Stabilizing formulation for NGF
12/09/1998CN1201384A Aerosol compositions
12/09/1998CN1201037A 5'-deoxy-cytidine derivatives
12/09/1998CN1200922A Method for scavenging free radical by orange extracted liquor
12/09/1998CN1041091C Trisubstituted pyrimido (5,4-d) pyrimidines for modulating multi-medicine resistance, medicinal composition containing said compound and preparation
12/09/1998CN1041087C Arylacetamides, preparation method and use thereof
12/09/1998CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors
12/09/1998CA2231015A1 Novel compounds
12/08/1998US5847124 Hydrated forms of zilpatherol hydrochloride
12/08/1998US5847107 Method of preparing mixed glucosamine salts
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847086 Therapeutic fragments of von Willebrand factor
12/08/1998US5847085 Modified protein C and methods of use thereof
12/08/1998US5847084 Process for obtaining platelet factor-4
12/08/1998US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846990 Substituted biphenyl isoxazole sulfonamides
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998US5846987 Retroviral protease inhibiting compounds
12/08/1998US5846982 Inhibition of serotonin reuptake
12/08/1998US5846979 N-oxides of heterocyclic esters, amides, thioesters, and ketones
12/08/1998US5846976 Androstenone derivative
12/08/1998US5846972 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998US5846970 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998US5846968 N-substituted azaheterocyclic carboxylic acids and esters
12/08/1998US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998US5846810 Human 26S proteasome subunit components
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846714 Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/08/1998CA2026671C 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054324A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054217A1 Angiostatin fragments and method of use
12/03/1998WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998WO1998054207A1 Anti-inflammatory tyrosine derivatives
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054186A1 Salts of aromatic sulphonic acids
12/03/1998WO1998054185A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones
12/03/1998WO1998054183A2 Ergoline derivatives and their use as somatostatin receptor antagonists
12/03/1998WO1998054182A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054178A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054166A1 A new salt
1 ... 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 ... 1564